N.F.U. Mutual Unit Managers Ltd’s Bristol-Myers Squibb BMY Stock Holding History

N.F.U. Mutual Unit Managers Ltd’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.73M	Buy	+27,704	New	+$1.75M	0.31%	88

Other funds holding BMY

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Independent Franchise Partners London, United Kingdom $16.1B AUM 4.39% 1-Year Est. Return

N.F.U. Mutual Unit Managers Ltd's BMY Position: Q3 2026 in Review

N.F.U. Mutual Unit Managers Ltd opened a new position in Bristol-Myers Squibb (BMY) in Q3 2026: 27,704 shares worth $1.73M. The stake represents 0.31% of the portfolio and ranks #88 among its holdings.

2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

N.F.U. Mutual Unit Managers Ltd held 27,704 shares of Bristol-Myers Squibb worth $1.73M as of Q3 2026.
Bristol-Myers Squibb was a new N.F.U. Mutual Unit Managers Ltd position in Q3 2026.
Bristol-Myers Squibb made up 0.31% of N.F.U. Mutual Unit Managers Ltd's portfolio in Q3 2026, its #88 holding.
2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on N.F.U. Mutual Unit Managers Ltd's 13F filing for Q3 2026, filed 12 Nov 2026.